CervoMed Inc. News

Latest updates and market news for CRVO

3 news

Mar 14 - Mar 20, 2026

Page 1

CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology

GlobeNewswire

a day ago

CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology

MT Newswires

2 days ago

Chardan Raises Price Target on CervoMed to $21 From $15, Keeps Buy Rating

CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

3 days ago

CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates

📈

AI Sentiment

Highly Positive

9/10

Share this news page

Share on Social Networks: